276 related articles for article (PubMed ID: 37071295)
21. Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
Niyazi M; Harter PN; Hattingen E; Rottler M; von Baumgarten L; Proescholdt M; Belka C; Lauber K; Mittelbronn M
Oncotarget; 2016 Jan; 7(3):2313-28. PubMed ID: 26575171
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
23. The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential.
Anthony C; Mladkova-Suchy N; Adamson DC
Expert Opin Investig Drugs; 2019 Sep; 28(9):787-797. PubMed ID: 31356114
[No Abstract] [Full Text] [Related]
24. Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy.
Fraum TJ; Kreisl TN; Sul J; Fine HA; Iwamoto FM
J Neurooncol; 2011 Nov; 105(2):281-9. PubMed ID: 21603965
[TBL] [Abstract][Full Text] [Related]
25. Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence.
Wick W; Wick A; Weiler M; Weller M
Curr Neurol Neurosci Rep; 2011 Jun; 11(3):305-12. PubMed ID: 21279815
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis inhibitors in tackling recurrent glioblastoma.
Hundsberger T; Reardon DA; Wen PY
Expert Rev Anticancer Ther; 2017 Jun; 17(6):507-515. PubMed ID: 28438066
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic therapies for glioblastoma.
Arrillaga-Romany I; Norden AD
CNS Oncol; 2014; 3(5):349-58. PubMed ID: 25363007
[TBL] [Abstract][Full Text] [Related]
28. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis and antiangiogenic therapy for malignant gliomas.
Takano S; Kamiyama H; Tsuboi K; Matsumura A
Brain Tumor Pathol; 2004; 21(2):69-73. PubMed ID: 15700836
[TBL] [Abstract][Full Text] [Related]
30. A vasculature-centric approach to developing novel treatment options for glioblastoma.
Wirsching HG; Roth P; Weller M
Expert Opin Ther Targets; 2021 Feb; 25(2):87-100. PubMed ID: 33482697
[No Abstract] [Full Text] [Related]
31. Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.
Lu-Emerson C; Duda DG; Emblem KE; Taylor JW; Gerstner ER; Loeffler JS; Batchelor TT; Jain RK
J Clin Oncol; 2015 Apr; 33(10):1197-213. PubMed ID: 25713439
[TBL] [Abstract][Full Text] [Related]
32. Bevacizumab antiangiogenic therapy for glioblastoma.
Junck L
Neurology; 2011 Feb; 76(5):414-5. PubMed ID: 21282587
[No Abstract] [Full Text] [Related]
33. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
34. CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.
Angara K; Borin TF; Rashid MH; Lebedyeva I; Ara R; Lin PC; Iskander A; Bollag RJ; Achyut BR; Arbab AS
Neoplasia; 2018 Oct; 20(10):1070-1082. PubMed ID: 30236892
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of evasion to antiangiogenic therapy in glioblastoma.
Rose SD; Aghi MK
Clin Neurosurg; 2010; 57():123-8. PubMed ID: 21280504
[No Abstract] [Full Text] [Related]
36. Antiangiogenic therapy for glioblastoma.
Gerstner ER; Batchelor TT
Cancer J; 2012; 18(1):45-50. PubMed ID: 22290257
[TBL] [Abstract][Full Text] [Related]
37. β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.
Carbonell WS; DeLay M; Jahangiri A; Park CC; Aghi MK
Cancer Res; 2013 May; 73(10):3145-54. PubMed ID: 23644530
[TBL] [Abstract][Full Text] [Related]
38. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
39. Neutrophils promote the malignant glioma phenotype through S100A4.
Liang J; Piao Y; Holmes L; Fuller GN; Henry V; Tiao N; de Groot JF
Clin Cancer Res; 2014 Jan; 20(1):187-98. PubMed ID: 24240114
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic therapy of brain tumors: the role of bevacizumab.
Trevisan E; Bertero L; Bosa C; Magistrello M; Pellerino A; Rudà R; Soffietti R
Neurol Sci; 2014 Apr; 35(4):507-14. PubMed ID: 24442487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
